Latest Us Tariffs News

MyEco Group’s FY26 retail sales edged up 0.8% to $15.8 million, powered by a 22.7% surge in Australian branded product sales and a successful launch of certified recycled bin liners at Woolworths.

Skellerup has raised its FY26 net profit after tax forecast to $64-$65 million, driven by robust demand in the US and New Zealand markets, improved supply chain conditions, and favourable currency and tariff impacts.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

Reliance Worldwide Corporation plans to shutter its brass manufacturing in Melbourne, citing declining volumes tied to automation and supply chain shifts, while targeting a US$9 million boost to operating earnings by FY27.

Whitefield Industrials delivered a $21.1 million net profit for FY2026, upheld its long-standing dividend track record, and outperformed its benchmark despite geopolitical tensions and market volatility.

Delegat Group has raised its full-year Operating Net Profit after Tax forecast to $60-62 million, up from $50-55 million, driven by stronger global sales, lower US tariffs, and favourable FX.

Steel & Tube has secured a one-year extension on its ANZ banking facilities, underpinning financial stability as trading conditions soften due to geopolitical tensions and sector-specific pressures.

Templeton Emerging Markets Investment Trust (TEMIT) posted a robust 41.3% net asset value total return for FY2026, outpacing its benchmark and narrowing its share price discount, while maintaining dividends and expanding share buybacks.

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

AoFrio Limited has secured NZ$4.56 million through a share placement to existing investor Wairahi Investments, underpinning a bold strategy to boost revenue growth to 25% annually. A follow-up rights issue will allow current shareholders to participate at the same price.